Could the kinetin riboside be used to inhibit human prostate cell epithelial–mesenchymal transition?Joanna Dulińska-Litewka(Jagiellonian University), Krzysztof Okoń(Jagiellonian University)Medical OncologyFebruary 6, 202010.1007/s12032-020-1338-1Cited by 9SaveCiteExport RISWatch citationsRelated PapersSuperparamagnetic Iron Oxide Nanoparticles—Current and Prospective Medical Applications|Materials|2019|562